Anti-BHK: HR conentrate antibody
To Order Contact us: bjorn@lembcke.dk
 Anti-HR antibody |
|||
| STJ113899 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene encodes a protein that is involved in hair growth. This protein functions as a transcriptional corepressor of multiple nuclear receptors, including thyroid hormone receptor, the retinoic acid receptor-related orphan receptors and the vitamin D receptors, and it interacts with histone deacetylases. The translation of this protein is modulated by a regulatory open reading frame (ORF) that exists upstream of the primary ORF. Mutations in this upstream ORF cause Marie Unna hereditary hypotrichosis (MUHH), an autosomal dominant form of genetic hair loss. Mutations in this gene also cause autosomal recessive congenital alopecia and atrichia with papular lesions, other diseases resulting in hair loss. Two transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-HR antibody |
|||
| STJ114068 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene encodes a protein that is involved in hair growth. This protein functions as a transcriptional corepressor of multiple nuclear receptors, including thyroid hormone receptor, the retinoic acid receptor-related orphan receptors and the vitamin D receptors, and it interacts with histone deacetylases. The translation of this protein is modulated by a regulatory open reading frame (ORF) that exists upstream of the primary ORF. Mutations in this upstream ORF cause Marie Unna hereditary hypotrichosis (MUHH), an autosomal dominant form of genetic hair loss. Mutations in this gene also cause autosomal recessive congenital alopecia and atrichia with papular lesions, other diseases resulting in hair loss. Two transcript variants encoding different isoforms have been found for this gene. |
|||
 anti-HR |
|||
| YF-PA26367 | Abfrontier | 50 ul | EUR 334 |
|
Description: Mouse polyclonal to HR |
|||
 Rabbit Polyclonal antibody Anti-CRBN |
|||
| Anti-CRBN | ImmunoStep | 50 µg | EUR 349 |
 Anti-BHK: HRP Conjugate Concentrate |
|||
| F511C | Cygnus Technologies | 1 mg | EUR 4993 |
|
|||
|
Description: Anti-BHK: HRP Conjugate Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
 HR antibody |
|||
| 10R-1575 | Fitzgerald | 100 ug | EUR 512 |
|
Description: Mouse monoclonal HR antibody |
|||
 HR Antibody |
|||
| 1-CSB-PA002859 | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against HR. Recognizes HR from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/10000 |
|||
HR Antibody |
|||
| CSB-PA776465- | Cusabio | EUR 335 | |
|
|||
|
Description: A polyclonal antibody against HR. Recognizes HR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
HR Antibody |
|||
| CSB-PA776465-100ul | Cusabio | 100ul | EUR 316 |
|
|||
|
Description: A polyclonal antibody against HR. Recognizes HR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
|||
 HR Polyclonal Antibody |
|||
| 27586-100ul | SAB | 100ul | EUR 252 |
HR Polyclonal Antibody |
|||
| 27586-50ul | SAB | 50ul | EUR 187 |
HR Polyclonal Antibody |
|||
| 27636-100ul | SAB | 100ul | EUR 252 |
HR Polyclonal Antibody |
|||
| 27636-50ul | SAB | 50ul | EUR 187 |
 Hr/ Rat Hr ELISA Kit |
|||
| ELI-30862r | Lifescience Market | 96 Tests | EUR 886 |
 BHK HCP ELISA kit |
|||
| F510 | Cygnus Technologies | 1 kit (96 wells plate) | EUR 1080 |
|
|||
|
Description: BHK HCP ELISA kit by Cygnus Technologies is available in Europe via Gentaur. |
|||
 BHK HCP Antigen Concentrate |
|||
| F513G | Cygnus Technologies | 400 ul | EUR 527 |
|
|||
|
Description: BHK HCP Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
 HR siRNA |
|||
| 20-abx919861 | Abbexa |
|
|
|
|||
HR siRNA |
|||
| 20-abx919862 | Abbexa |
|
|
|
|||
 Agarose HR |
|||
| A-1280-100 | ABTBeads | 100 g | EUR 183 |
Agarose HR |
|||
| A-1280-500 | ABTBeads | 500 g | EUR 685 |
 Antibody) HR, Lysine Demethylase And Nuclear Receptor Corepressor (HR) Antibody |
|||
| 20-abx125963 | Abbexa |
|
|
|
|||
HR, Lysine Demethylase And Nuclear Receptor Corepressor (HR) Antibody |
|||
| 20-abx125964 | Abbexa |
|
|
|
|||
HR, Lysine Demethylase And Nuclear Receptor Corepressor (HR) Antibody |
|||
| 20-abx324817 | Abbexa |
|
|
|
|||
HR, Lysine Demethylase And Nuclear Receptor Corepressor (HR) Antibody |
|||
| abx330552-100ul | Abbexa | 100 ul | EUR 425 |
|
|||
 HR Polyclonal Conjugated Antibody |
|||
| C27586 | SAB | 100ul | EUR 397 |
HR Polyclonal Conjugated Antibody |
|||
| C27636 | SAB | 100ul | EUR 397 |
 Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | EUR 280 |
 Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | EUR 280 |
 Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | EUR 280 |
 HR Rabbit pAb |
|||
| A11996-100ul | Abclonal | 100 ul | EUR 308 |
HR Rabbit pAb |
|||
| A11996-200ul | Abclonal | 200 ul | EUR 459 |
HR Rabbit pAb |
|||
| A11996-20ul | Abclonal | 20 ul | EUR 183 |
HR Rabbit pAb |
|||
| A11996-50ul | Abclonal | 50 ul | EUR 223 |
HR Rabbit pAb |
|||
| A12175-100ul | Abclonal | 100 ul | EUR 308 |
HR Rabbit pAb |
|||
| A12175-200ul | Abclonal | 200 ul | EUR 459 |
HR Rabbit pAb |
|||
| A12175-20ul | Abclonal | 20 ul | EUR 183 |
HR Rabbit pAb |
|||
| A12175-50ul | Abclonal | 50 ul | EUR 223 |
 25G AquaPor HR |
|||
| NAT1034 | National Diagnostics | 25G | EUR 197 |
 100G AquaPor HR |
|||
| NAT1036 | National Diagnostics | 100G | EUR 494 |
 BHK Cell HCP Standards A-F |
|||
| F513 | Cygnus Technologies | 1 ml | EUR 527 |
|
|||
|
Description: BHK Cell HCP Standards A-F by Cygnus Technologies is available in Europe via Gentaur. |
|||
 BHK Cell Serum-Free Medium-1 |
|||
| VCum-Lsx0017 | Creative Biolabs | 1 L | EUR 647 |
|
Description: BHK cell serum-free medium has been specifically developed for suspension culture of BHK cells. |
|||
 BHK Cell Serum-Free Medium-2 |
|||
| VCum-Lsx0019 | Creative Biolabs | 1 L | EUR 717 |
|
Description: Used in serum-free suspension BHK cell line culture for newcastle disease virus production. |
|||
 Mouse HR shRNA Plasmid |
|||
| 20-abx970890 | Abbexa |
|
|
|
|||
 Human HR shRNA Plasmid |
|||
| 20-abx960936 | Abbexa |
|
|
|
|||
) BHK Cell Serum-Free Medium-1 (Powder) |
|||
| VCum-Lsx0018-10L | Creative Biolabs | 10 L | EUR 1688 |
|
Description: BHK cellserum-free medium has been specifically developed for suspension culture of BHK cells. |
|||
BHK Cell Serum-Free Medium-1 (Powder) |
|||
| VCum-Lsx0018-1L | Creative Biolabs | 1 L | EUR 214 |
|
Description: BHK cellserum-free medium has been specifically developed for suspension culture of BHK cells. |
|||
BHK Cell Serum-Free Medium-1 (Powder) |
|||
| VCum-Lsx0018-5L | Creative Biolabs | 5 L | EUR 869 |
|
Description: BHK cellserum-free medium has been specifically developed for suspension culture of BHK cells. |
|||
) BHK Cell Serum-Free Medium-2 (Powder) |
|||
| VCum-Lsx0020-10L | Creative Biolabs | 10 L | EUR 1922 |
|
Description: Used in serum-free suspension BHK cell line culture for newcastle disease virus production. |
|||
BHK Cell Serum-Free Medium-2 (Powder) |
|||
| VCum-Lsx0020-1L | Creative Biolabs | 1 L | EUR 237 |
|
Description: Used in serum-free suspension BHK cell line culture for newcastle disease virus production. |
|||
BHK Cell Serum-Free Medium-2 (Powder) |
|||
| VCum-Lsx0020-5L | Creative Biolabs | 5 L | EUR 986 |
|
Description: Used in serum-free suspension BHK cell line culture for newcastle disease virus production. |
|||
 PinPoint-HR attP Placement Vector ? Empty MCS for cloning HR Arms |
|||
| PIN400A-1 | SBI | 10ug | EUR 1268 |
|
|||
) 16.5x14 cellogel 190µ hr (10) |
|||
| EHCA1200-SH09-10 | Consort | ea | EUR 69 |
) 17x17 cellogel 190µ hr (10) |
|||
| EHCA1200-SH14-10 | Consort | ea | EUR 87 |
) 20.5x20.5 cellogel 190µ hr (10) |
|||
| EHCA1200-SH19-10 | Consort | ea | EUR 214 |
) 30x30 cellogel 190µ hr (10) |
|||
| EHCA1200-SH24-10 | Consort | ea | EUR 433 |
) 18.3x14 cellogel 190µ hr (10) |
|||
| EHCA1200-SH27-10 | Consort | ea | EUR 141 |
) 18.3x17 cellogel 190µ hr (10) |
|||
| EHCA1200-SH32-10 | Consort | ea | EUR 169 |
) 2.5x14 cellogel 190µ hr (100) |
|||
| EHCA1200-ST08-100 | Consort | ea | EUR 105 |
2.5x14 cellogel 190µ hr (100) |
|||
| EHCA1200-ST09-25 | Consort | ea | EUR 41 |
) 2.5x17 cellogel 190µ hr (100) |
|||
| EHCA1200-ST13-100 | Consort | ea | EUR 123 |
) 4x17 cellogel 190µ hr (100) |
|||
| EHCA1200-ST23-100 | Consort | ea | EUR 169 |
) 5.7x14 cellogel 190µ hr (100) |
|||
| EHCA1200-ST38-100 | Consort | ea | EUR 160 |
 (pORF)) Hr ORF Vector (Rat) (pORF) |
|||
| ORF068352 | ABM | 1.0 ug DNA | EUR 506 |
 (pORF)) Hr ORF Vector (Mouse) (pORF) |
|||
| ORF047451 | ABM | 1.0 ug DNA | EUR 506 |
 (pORF)) HR ORF Vector (Human) (pORF) |
|||
| ORF021148 | ABM | 1.0 ug DNA | EUR 405 |
ELISA Kit) Human Hairless(HR)ELISA Kit |
|||
| QY-E04879 | Qayee Biotechnology | 96T | EUR 361 |
 Medium-1) BHK Cell Low Serum (0-2%) Medium-1 |
|||
| VCum-Lsx0013 | Creative Biolabs | 1 L | EUR 670 |
|
Description: BHK cell low serum medium has been specifically developed for suspension culture of BHK cells. |
|||
 Medium-2) BHK Cell Low Serum (0-2%) Medium-2 |
|||
| VCum-Lsx0015 | Creative Biolabs | 1 L | EUR 658 |
|
Description: BHK cell low serum medium has been specifically developed for suspension culture of BHK cells. |
|||
 Medium-1 (Powder)) BHK Cell Low Serum (0-2%) Medium-1 (Powder) |
|||
| VCum-Lsx0014-10L | Creative Biolabs | 10 L | EUR 1805 |
|
Description: BHK cell low serum medium has been specifically developed for suspension culture of BHK cells. |
|||
BHK Cell Low Serum (0-2%) Medium-1 (Powder) |
|||
| VCum-Lsx0014-1L | Creative Biolabs | 1 L | EUR 226 |
|
Description: BHK cell low serum medium has been specifically developed for suspension culture of BHK cells. |
|||
BHK Cell Low Serum (0-2%) Medium-1 (Powder) |
|||
| VCum-Lsx0014-5L | Creative Biolabs | 5 L | EUR 928 |
|
Description: BHK cell low serum medium has been specifically developed for suspension culture of BHK cells. |
|||
 Medium-2 (Powder)) BHK Cell Low Serum (0-2%) Medium-2 (Powder) |
|||
| VCum-Lsx0016-10L | Creative Biolabs | 10 L | EUR 1747 |
|
Description: BHK cell low serum medium has been specifically developed for suspension culture of BHK cells. |
|||
BHK Cell Low Serum (0-2%) Medium-2 (Powder) |
|||
| VCum-Lsx0016-1L | Creative Biolabs | 1 L | EUR 220 |
|
Description: BHK cell low serum medium has been specifically developed for suspension culture of BHK cells. |
|||
BHK Cell Low Serum (0-2%) Medium-2 (Powder) |
|||
| VCum-Lsx0016-5L | Creative Biolabs | 5 L | EUR 898 |
|
Description: BHK cell low serum medium has been specifically developed for suspension culture of BHK cells. |
|||
) 2.55x14.5 cellogel 190µ boskamp hr (25) |
|||
| EHCA1200-ST59-25 | Consort | ea | EUR 38 |
) 7.8x15 cellogel 190µ shandon hr (25) |
|||
| EHCA1200-ST64-25 | Consort | ea | EUR 78 |
 Human Protein hairless, HR ELISA KIT |
|||
| ELI-30861h | Lifescience Market | 96 Tests | EUR 824 |
 Mouse Protein hairless, Hr ELISA KIT |
|||
| ELI-38416m | Lifescience Market | 96 Tests | EUR 865 |
 Rat ; NRK 0 hr log phase |
|||
| 02-717 | Sceti | 100ng | EUR 401 |
|
Description: The Rat ; NRK 0 hr log phase is available in Europe and for worldwide shipping via Gentaur. |
|||
) Hr sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3827001 | ABM | 3 x 1.0 ug | EUR 339 |
) HR sgRNA CRISPR Lentivector set (Human) |
|||
| K0988501 | ABM | 3 x 1.0 ug | EUR 339 |
) Hr sgRNA CRISPR Lentivector set (Rat) |
|||
| K6919301 | ABM | 3 x 1.0 ug | EUR 339 |
 HyAgarose? HR Agarose, PCR Grade, 100g |
|||
| R9012HR-100g | ACTGene | EUR 332 | |
 HyAgarose? HR Agarose, PCR Grade, 10g |
|||
| R9012HR-10g | ACTGene | EUR 83 | |
 HyAgarose? HR Agarose, PCR Grade, 500g |
|||
| R9012HR-500g | ACTGene | EUR 1141 | |
 HyAgarose? HR Agarose, PCR Grade, 50g |
|||
| R9012HR-50g | ACTGene | EUR 202 | |
) 5.7x14 cellogel 190µ pratiga punched hr (25) |
|||
| EHCA1200-ST44-25 | Consort | ea | EUR 56 |
) 5.7x14.5 cellogel 190µ beckman punched hr (25) |
|||
| EHCA1200-ST54-25 | Consort | ea | EUR 56 |
 Peptide HR-1) Mast Cell Degranulating (MCD) Peptide HR-1 |
|||
| H-8375.0005 | Bachem | 5.0mg | EUR 273 |
|
Description: Sum Formula: C71H133N19O15; CAS# [80533-94-4] |
|||
Mast Cell Degranulating (MCD) Peptide HR-1 |
|||
| H-8375.0025 | Bachem | 25.0mg | EUR 998 |
|
Description: Sum Formula: C71H133N19O15; CAS# [80533-94-4] |
|||
 Peptide HR-2) Mast Cell Degranulating (MCD) Peptide HR-2 |
|||
| H-8390.0005 | Bachem | 5.0mg | EUR 273 |
|
Description: Sum Formula: C77H135N17O14; CAS# [80388-04-1] |
|||
Mast Cell Degranulating (MCD) Peptide HR-2 |
|||
| H-8390.0025 | Bachem | 25.0mg | EUR 998 |
|
Description: Sum Formula: C77H135N17O14; CAS# [80388-04-1] |
|||
Mast Cell Degranulating (MCD) Peptide HR-1 |
|||
| 5-01511 | CHI Scientific | 4 x 1mg | Ask for price |
Mast Cell Degranulating (MCD) Peptide HR-2 |
|||
| 5-01512 | CHI Scientific | 4 x 1mg | Ask for price |
 (Target 1)) Hr sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K3827002 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) Hr sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3827003 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) Hr sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K3827004 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 1)) HR sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0988502 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) HR sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0988503 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) HR sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0988504 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 1)) Hr sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K6919302 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) Hr sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K6919303 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) Hr sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K6919304 | ABM | 1.0 ug DNA | EUR 154 |
 (pPB-C-His)) HR Protein Vector (Human) (pPB-C-His) |
|||
| PV084589 | ABM | 500 ng | EUR 811 |
 (pPB-N-His)) HR Protein Vector (Human) (pPB-N-His) |
|||
| PV084590 | ABM | 500 ng | EUR 811 |
 (pPM-C-HA)) HR Protein Vector (Human) (pPM-C-HA) |
|||
| PV084591 | ABM | 500 ng | EUR 811 |
 (pPM-C-His)) HR Protein Vector (Human) (pPM-C-His) |
|||
| PV084592 | ABM | 500 ng | EUR 811 |
 (pPB-C-His)) HR Protein Vector (Rat) (pPB-C-His) |
|||
| PV273406 | ABM | 500 ng | EUR 1191 |
 (pPB-N-His)) HR Protein Vector (Rat) (pPB-N-His) |
|||
| PV273407 | ABM | 500 ng | EUR 1191 |
 (pPM-C-HA)) HR Protein Vector (Rat) (pPM-C-HA) |
|||
| PV273408 | ABM | 500 ng | EUR 1191 |
 (pPM-C-His)) HR Protein Vector (Rat) (pPM-C-His) |
|||
| PV273409 | ABM | 500 ng | EUR 1191 |
 (pPB-C-His)) HR Protein Vector (Mouse) (pPB-C-His) |
|||
| PV189802 | ABM | 500 ng | EUR 1065 |
 (pPB-N-His)) HR Protein Vector (Mouse) (pPB-N-His) |
|||
| PV189803 | ABM | 500 ng | EUR 1065 |
 (pPM-C-HA)) HR Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV189804 | ABM | 500 ng | EUR 1065 |
 (pPM-C-His)) HR Protein Vector (Mouse) (pPM-C-His) |
|||
| PV189805 | ABM | 500 ng | EUR 1065 |
 Hr 3'UTR Luciferase Stable Cell Line |
|||
| TU205946 | ABM | 1.0 ml | Ask for price |
 Hr 3'UTR GFP Stable Cell Line |
|||
| TU159729 | ABM | 1.0 ml | Ask for price |
 HR 3'UTR Luciferase Stable Cell Line |
|||
| TU010151 | ABM | 1.0 ml | EUR 1394 |
Hr 3'UTR Luciferase Stable Cell Line |
|||
| TU109729 | ABM | 1.0 ml | Ask for price |
 HR 3'UTR GFP Stable Cell Line |
|||
| TU060151 | ABM | 1.0 ml | EUR 1394 |
Hr 3'UTR GFP Stable Cell Line |
|||
| TU255946 | ABM | 1.0 ml | Ask for price |
) Truncated plaque-size/host range protein (PS/HR) |
|||
| 1-CSB-BP335028VAF | Cusabio |
|
|
|
|||
|
Description: Recombinant Truncated plaque-size/host range protein(PS/HR) expressed in Baculovirus |
|||
 (CMV) (pLenti-GIII-CMV)) HR Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV698527 | ABM | 1.0 ug DNA | EUR 1355 |
 (UbC) (pLenti-GIII-UbC)) HR Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV698531 | ABM | 1.0 ug DNA | EUR 1355 |
 (EF1a) (pLenti-GIII-EF1a)) HR Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV698532 | ABM | 1.0 ug DNA | EUR 1355 |
) Vaccinia virus Plaque-size/host range protein (PS/HR) |
|||
| 1-CSB-YP328444VAG | Cusabio |
|
|
|
|||
|
Description: Recombinant Vaccinia virus Plaque-size/host range protein(PS/HR),partial expressed in Yeast |
|||
Vaccinia virus Plaque-size/host range protein (PS/HR) |
|||
| 1-CSB-EP312446VAI | Cusabio |
|
|
|
|||
|
Description: Recombinant Vaccinia virus Plaque-size/host range protein(PS/HR),partial expressed in E.coli |
|||
Vaccinia virus Plaque-size/host range protein (PS/HR) |
|||
| 1-CSB-CF328444VAG1 | Cusabio |
|
|
|
|||
|
Description: Recombinant Vaccinia virus Plaque-size/host range protein(PS/HR),partial expressed in in vitro E.coli expression system |
|||
 antibody (IgG) ELISA kit) Human high risk papillomavirus L1-capsids (HR-HPVL1) antibody (IgG) ELISA kit |
|||
| CSB-EQ027478HU-24T | Cusabio | 1 plate of 24 wells | EUR 165 |
|
|||
|
Description: Qualitativeindirect ELISA kit for measuring Human high risk papillomavirus L1-capsids (HR-HPVL1) antibody (IgG) in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human high risk papillomavirus L1-capsids (HR-HPVL1) antibody (IgG) ELISA kit |
|||
| 1-CSB-EQ027478HU | Cusabio |
|
|
|
|||
|
Description: Qualitativeindirect ELISA kit for measuring Human high risk papillomavirus L1-capsids (HR-HPVL1) antibody (IgG) in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
) Hr sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K3827005 | ABM | 3 x 1.0 ug | EUR 376 |
) HR based Kit in HeLa Requiring CRISPR Transfection (50ug DNA) |
|||
| DR3000-HRHeLa-CPR | TopoGen | 50ug DNA | EUR 2749 |
) HR based Kit in HeLa Requiring CRISPR Transfection (100ug DNA) |
|||
| DR3000-HRHeLa-CPR2 | TopoGen | 100ug DNA | EUR 3009 |
) HR based Kit in HeLa Requiring CRISPR Transfection (250ug DNA) |
|||
| DR3000-HRHeLa-CPR3 | TopoGen | 250ug DNA | EUR 3529 |
) Vaccinia virus Truncated plaque-size/host range protein (PS/HR) |
|||
| 1-CSB-YP335028VAF | Cusabio |
|
|
|
|||
|
Description: Recombinant Vaccinia virus Truncated plaque-size/host range protein(PS/HR) expressed in Yeast |
|||
Vaccinia virus Truncated plaque-size/host range protein (PS/HR) |
|||
| 1-CSB-EP335028VAF | Cusabio |
|
|
|
|||
|
Description: Recombinant Vaccinia virus Truncated plaque-size/host range protein(PS/HR) expressed in E.coli |
|||
) HR sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0988505 | ABM | 3 x 1.0 ug | EUR 376 |
) Hr sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K6919305 | ABM | 3 x 1.0 ug | EUR 376 |
 (Target 1)) Hr sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K3827006 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) Hr sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K3827007 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) Hr sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K3827008 | ABM | 1.0 ug DNA | EUR 167 |
) HR based Kit in HeLa Requiring I-Sce1 Transfection (50ug DNA) |
|||
| DR3000-HRHeLa-Sce | TopoGen | 50ug DNA | EUR 2645 |
) HR based Kit in HeLa Requiring I-Sce1 Transfection (100ug DNA) |
|||
| DR3000-HRHeLa-Sce2 | TopoGen | 100ug DNA | EUR 2905 |
) HR based Kit in HeLa Requiring I-Sce1 Transfection (250ug DNA) |
|||
| DR3000-HRHeLa-Sce3 | TopoGen | 250ug DNA | EUR 3425 |
) HR in human Neuroblastoma Cells req. I-Sce1 Transfection (50ug DNA) |
|||
| DR3000-HRSH-Sce | TopoGen | 50ug DNA | EUR 2853 |
) HR in human Neuroblastoma Cells req. I-Sce1 Transfection (100ug DNA) |
|||
| DR3000-HRSH-Sce2 | TopoGen | 100ug DNA | EUR 3113 |
) HR in human Neuroblastoma Cells req. I-Sce1 Transfection (250ug DNA) |
|||
| DR3000-HRSH-Sce3 | TopoGen | 250ug DNA | EUR 3633 |
 (Target 1)) HR sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K0988506 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) HR sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K0988507 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) HR sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K0988508 | ABM | 1.0 ug DNA | EUR 167 |
 (CMV) (pLenti-GIII-CMV-C-term-HA)) HR Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV698528 | ABM | 1.0 ug DNA | EUR 1355 |
 (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)) HR Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV698529 | ABM | 1.0 ug DNA | EUR 1413 |
 (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)) HR Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV698530 | ABM | 1.0 ug DNA | EUR 1413 |
 (Target 1)) Hr sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K6919306 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 2)) Hr sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
| K6919307 | ABM | 1.0 ug DNA | EUR 167 |
 (Target 3)) Hr sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
| K6919308 | ABM | 1.0 ug DNA | EUR 167 |
 PinPoint-HR attP Placement Vector ? for targeting the Human AAVS1 Safe Harbor |
|||
| PIN410A-1 | SBI | 10ug | EUR 1268 |
|
|||
 Gene Knock-Out HR Targeting Vector [MCS1-EF1?-RFP-T2A-Puro-pA-MCS2] |
|||
| HR110PA-1 | SBI | 10 ug | EUR 1023 |
|
|||
 Gene Knock-Out HR Targeting Vector [MCS1-EF1a-GFP-T2A-Puro-pA-MCS2] |
|||
| HR410PA-1 | SBI | 10 ug | EUR 1023 |
|
|||
 Gene Knock-Out HR Targeting Vector [MCS1-EF1a-RFP-T2A-Hygro-pA-MCS2] |
|||
| HR510PA-1 | SBI | 10 ug | EUR 1023 |
|
|||
) HR based Kit in MOUSE 3T3 Cells Requiring I-Sce1 Transfection (50ug DNA) |
|||
| DR3000-HR3T3-Sce | TopoGen | 50ug DNA | EUR 2645 |
) HR based Kit in MOUSE 3T3 Cells Requiring I-Sce1 Transfection (100ug DNA) |
|||
| DR3000-HR3T3-Sce2 | TopoGen | 100ug DNA | EUR 2905 |
) HR based Kit in MOUSE 3T3 Cells Requiring I-Sce1 Transfection (250ug DNA) |
|||
| DR3000-HR3T3-Sce3 | TopoGen | 250ug DNA | EUR 3425 |
) HR based Kit in Mouse Neuronal Cells Requiring I-Sce1 Transfection (50ug DNA) |
|||
| DR3000-HRCN1.4-Sce | TopoGen | 50ug DNA | EUR 2853 |
) HR based Kit in Mouse Neuronal Cells Requiring I-Sce1 Transfection (100ug DNA) |
|||
| DR3000-HRCN1.4-Sce2 | TopoGen | 100ug DNA | EUR 3113 |
) HR based Kit in Mouse Neuronal Cells Requiring I-Sce1 Transfection (250ug DNA) |
|||
| DR3000-HRCN1.4-Sce3 | TopoGen | 250ug DNA | EUR 3633 |
 HR Pooled Cell analysis: 50ug DR-HRGFP, 50ug pSce1, 25ug e-GFP, Puromycin |
|||
| DR3050 | TopoGen | 1 | EUR 1813 |
 HR Pooled Cell analysis: 1000ug DR-HRGFP, 10000ug pSce1, 25ug e-GFP, Puromycin |
|||
| DR31000 | TopoGen | 1 | EUR 2853 |
 HR Pooled Cell analysis: 500ug DR-HRGFP, 500ug pSce1, 25ug e-GFP, Puromycin |
|||
| DR3500 | TopoGen | 1 | EUR 2645 |
 Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ28365 | St John's Laboratory | 100 µl | EUR 277 |
 Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ28963 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
 Anti-Anti-SEPT6 antibody antibody |
|||
| STJ11100949 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
|||
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ25475 | St John's Laboratory | 100 µl | EUR 277 |
 Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ25477 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
 Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ25479 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
 Anti-Anti-SEPT9 Antibody antibody |
|||
| STJ111369 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
|||
 Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ111530 | St John's Laboratory | 100 µl | EUR 277 |
 Anti-Anti-SEPT4 Antibody antibody |
|||
| STJ112276 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
|||
 Anti-Anti-MARCH9 Antibody antibody |
|||
| STJ112609 | St John's Laboratory | 100 µl | EUR 277 |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ113941 | St John's Laboratory | 100 µl | EUR 277 |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ114081 | St John's Laboratory | 100 µl | EUR 277 |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ114819 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
 Anti-Anti-MARCH8 Antibody antibody |
|||
| STJ114828 | St John's Laboratory | 100 µl | EUR 277 |
 Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118549 | St John's Laboratory | 100 µl | EUR 277 |
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118550 | St John's Laboratory | 100 µl | EUR 277 |
 Anti-Anti-MARCH7 Antibody antibody |
|||
| STJ118752 | St John's Laboratory | 100 µl | EUR 277 |